Search for: "Wyeth Pharmaceuticals"
Results 681 - 700
of 971
Sorted by Relevance
|
Sort by Date
2 Nov 2008, 4:00 am
Following the release of orders, the Court will hear argument in: Wyeth v. [read post]
31 Jan 2009, 6:50 am
The rule discourages medical device manufactures and pharmaceutical companies from updating warning labels with hazard information without prior FDA approval, a blatant attempt to influence the Supreme Court’s decision in Wyeth v. [read post]
30 Mar 2016, 8:00 am
Supreme Court decision in Wyeth v. [read post]
17 Mar 2010, 5:52 am
Other companies include Pfizer, Dell and Wyeth. [read post]
12 Oct 2010, 8:26 am
Pharmaceutical companies responded with a threat - they would stop making vaccines unless federal lawmakers shielded them from liability. [read post]
30 Mar 2016, 8:00 am
Supreme Court decision in Wyeth v. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva,… [read post]
14 Mar 2011, 11:12 am
Mensing: [In Wyeth v. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
9 May 2010, 5:15 am
Grassley, ask Wyeth and DesignWrite, a medical writing company [based in Princeton, NJ], to disclose payments related to the preparation of journal articles and the activities of doctors who were recruited to put their names on them for publication. [read post]
16 Sep 2011, 8:17 am
Teva Pharmaceuticals USA, Inc., 2011 U.S. [read post]
13 Feb 2009, 5:00 am
(PharmaLittle) US: PerkinElmer sues Interna to invalidate down syndrome test patent (Law360) US: Monsanto files patent suit against Michigan farmers Earl and Richard Schroeder accusing them of planting pesticide-resistant seeds without paying proper royalties (Law360) US: Case to watch: preclusive effect of prior claim construction: Shire v Sandoz (Patently-O) Products AndroGel (Testosterone) - US: Federal Trade Commission continues campaign against reverse payments, filing complaint… [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
2 Nov 2011, 2:00 am
Highlights this week included: WIPO Re:Search bridges public, private sectors for neglected disease research (IP Watch) (WIPO) (IPKat) (IP Watch) (Patent Docs) Section 3(d) equivalent in the offing for Thailand…(Spicy IP) Australia: FCAFC upholds claim by Alphapharm that claims 1 to 17 and 27 of Wyeth’s Venlafaxine patent are invalid (IP Whiteboard) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think… [read post]
4 Nov 2010, 1:24 pm
Wyeth Pharmaceuticals, 2010 WL 3431671 (E.D. [read post]
3 Jul 2013, 5:00 am
Wyeth, 621 F. [read post]
5 Feb 2013, 11:32 am
Wyeth Pharmaceuticals, 797 F. [read post]
6 Nov 2014, 5:00 am
Wyeth, 705 S.E.2d 828 (W. [read post]
8 Mar 2012, 10:08 am
Mutual Pharmaceutical Co., 2012 WL 465867 (D. [read post]
